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Sleep problems, including insomnia, apnea, and restless legs syndrome, are common, burdensome, and under-
recognized in the United States. We sought to examine the association of sleep problems with diabetes among 
community-dwelling US adults.
Methods 
We examined self-reported sleep problems in 9,848 adults (aged ≥20 y) participating in the National Health and 
Nutrition Examination Survey 2005 through 2008. Sleep problem information was elicited via validated questionnaire. 
Diabetes was defined by self-reported diagnosis or glycohemoglobin of 6.5% or higher. Multivariable logistic regression 
TM
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with US population-based weighting was used to obtain adjusted odds ratios (ORs) and 95% confidence intervals (CIs) 
for various sleep problems by diabetes status.
Results 
Sleep problems were common (>90% for any problem; 10%-40% for individual problems) overall, and people with 
diabetes were more likely than those without diabetes to report multiple problems (mean, 3.1 vs 2.5, respectively, P 
< .001). After adjustment for potential confounders (including demographics, body mass index, cardiovascular and 
kidney disease, and alcohol use), restless legs symptoms (OR, 1.40; 95% CI, 1.12-1.78), sleep apnea (OR, 1.45; 95% CI, 
1.06-1.98), and nocturia (OR, 1.51; 95% CI, 1.22-1.87) were all positively associated with diabetes status.
Conclusion 
Diabetes is associated with a higher risk of sleep problems, including not only sleep apnea but also inadequate sleep, 
excessive sleepiness, leg symptoms, and nocturia, independent of body mass index. Clinicians should be aware of the 
high prevalence of sleep problems among their patients with diabetes and should consider screening and treatment, 
which may improve patients’ quality of life.
Introduction
One-third of US adults report inadequate sleep (1). Sleep problems are associated with cardiovascular disease (2), 
mental health problems (3), motor vehicle accidents (4), and overall poor quality of life (5). The direct and indirect costs 
of sleep problems are substantial (6). Despite the individual and societal burden of sleep problems, most (80%-90%) 
remain undiagnosed (7).
Both diabetes (8) and sleep problems (5) are highly correlated with poor quality of life. People with diabetes may also be 
at higher risk for sleep problems relative to the general population because of common risk factors for diabetes and 
sleep problems, including advanced age, obesity, and treatments for and complications of common comorbid diseases 
(eg, depression, cardiovascular disease). Additionally, diabetes-specific complications, such as neuropathy, could 
directly interfere with sleep. However, because of low rates of detected sleep disorders (7), most people with diabetes 
who have sleep problems are likely to go untreated. Thus, estimating the prevalence of such undiagnosed sleep 
problems can help determine whether these problems are a public health concern.
Although there are more than 80 recognized sleep disorders (9), studies of diabetes and sleep have focused mainly on 
sleep apnea (10). Additionally, most studies of diabetes and sleep problems have lacked comparisons to the general 
population and have depended on the diagnosis of sleep disorder. We sought to examine the association of self-reported 
sleep problems — which are likely to be more prevalent than diagnosed sleep disorders — with diabetes among 
community-dwelling US adults, using data from the National Health and Nutrition Examination Survey (NHANES) 




NHANES is conducted by the Centers for Disease Control and Prevention (CDC) and consists of a standardized in-home 
interview followed by a physical examination at a mobile examination center. NHANES uses representative samples of 
noninstitutionalized US civilian residents. We limited our analysis to NHANES 2005 through 2008 adult (≥20 y) 
participants who responded to the sleep questionnaire and completed the examination (n = 9,848). NHANES 2005 
through 2006 and 2007 through 2008 reported response rates of 77.4% and 75.4% for the examined participants, 
respectively. All participants gave written informed consent. The National Center for Health Statistics Research Ethics 
Review Board approved the protocol.
Measurements
Questionnaire
Interviewers administered a questionnaire pertaining to sleep habits and sleep-related problems 
(www.cdc.gov/nchs/data/nhanes/nhanes_05_06/sp_slq_d.pdf), including items from 2 validated instruments: the 
Sleep Heart Health Study Sleep Habits Questionnaire (11) and the Functional Outcomes of Sleep Questionnaire (12). We 
have described individual items previously (13). Nocturia was an item on a separate kidney conditions – urology 
questionnaire (www.cdc.gov/nchs/data/nhanes/nhanes_05_06/sp_kiq_d.pdf). Participants self-reported 
demographics (age, sex, race/ethnicity), socioeconomic status and health care access (education, income, and health 
insurance coverage), and health status and conditions (diagnosis of diabetes, hypertension, and cardiovascular disease 
[CVD]; smoking and alcohol use; and depressive symptoms from the Patient Health Questionnaire-9 [PHQ-9] [14]) via 
questionnaire. The interviewer recorded prescription medications from the bottles provided by the participant.
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Examination and laboratory measurements
Laboratory personnel performed glycohemoglobin measurements using a high-performance liquid chromatography 
system and assessed fasting plasma glucose concentration by a hexokinase method. Laboratory personnel also 
measured serum and urine creatinine by the modified kinetic method of Jaffe and urine albumin using solid-phase 
fluorescence immunoassay. Examination personnel recorded anthropomorphic measurements (weight and height, used 
to calculate body mass index [BMI]) and blood pressure (≥3 auscultatory measurements).
Definitions
Sleep problems
We used inadequate sleep, sleep deprivation, daytime sleepiness, and sleeping pill use as markers of insomnia. We 
defined inadequate sleep as less than 7 total hours of sleep, according to National Sleep Foundation guidelines (15) 
(Box); we defined excess sleep as 9 or more hours per night. We defined severe sleep deprivation by sleep onset latency 
5 minutes or less (16). We considered daytime sleepiness and sleeping pill use to be frequent if they were reported 
“often” or more (≥5 times/mo). We defined apnea by frequent self-reported apnea, snorting, or gasping, or diagnosed 
sleep apnea. We defined nocturia as reported urination of 2 or more times per night. We included frequent self-reported 
leg jerks or cramps, or diagnosed restless legs syndrome as leg symptoms (Box).
Diabetes
We defined diabetes by self-report (answer of yes to the 
question, “Other than during pregnancy, have you ever 
been told by a doctor or other health care provider that 
you have diabetes or sugar diabetes?”) or 
glycohemoglobin of 6.5% or more (17). We did not 
include fasting plasma glucose of 126 mg/dL or more in 
the main definition because of the small sample of 
fasting morning participants (n = 4,770).
Other definitions
We defined self-reported diseases by answers of yes to 
the question, “Have you ever been told by a doctor or 
other health professional that you have [disease or 
condition].” We defined self-reported CVD by an answer 
of yes to any of coronary artery disease, angina, 
myocardial infarction, stroke, or congestive heart 
failure. We defined hypertension by self-report or by 
measured blood pressure of 140/90 mm Hg or higher. 
We defined depressive symptoms by at least 5 positive 
responses on the PHQ-9, along with reported functional 
impairment. We calculated estimated glomerular 
filtration rate (eGFR) according to the Modification of 
Diet in Renal Disease equation for isotope dilution mass 
spectrometry traceable creatinine (18). We defined 
albuminuria by a single urinary albumin:creatinine ratio 
of 30 mg/g or more.
Statistical analysis
We compared selected characteristics for participants 
with and without diabetes using χ  tests for categorical 
variables and t tests for continuous variables. We 
calculated prevalence of sleep problems by diabetes 
classification. We used multivariable logistic regression 
to obtain adjusted odds ratios (ORs) and 95% 
confidence intervals (CIs); covariates were chosen both 
for evidence of confounding and for parsimony. We 
performed sensitivity analyses with different definitions 
of diabetes among those not reporting sleeping pill use, 
with further covariates, and stratified by possible effect 
modifiers. All analyses were performed using Stata 
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version 10.0 (StataCorp LP, College Station, Texas) to 
account for study design weights, strata, and primary 
sampling units.
Results
Characteristics of US population by 
diabetes status
Participants with diabetes were older and more likely to 
be non-Hispanic black, to have no high school diploma, 
and to be insured than those without diabetes (Table 1). 
Relative to their counterparts, those with diabetes were 
less likely to be daily smokers, drank fewer alcoholic 
beverages per week, and were more likely to have 
obesity, depression, hypertension, cardiovascular 
disease, albuminuria, and reduced kidney function and 
to use diuretics (Table 1).
Prevalence of sleep problems
Overall, 93% of the adult US population reported at 
least 1 of the problems examined (Table 2). Leg 
symptoms (41%), inadequate sleep (37%), severe sleep 
deprivation (29%), and nocturia (25%) were the most 
commonly reported problems. While frequent sleeping 
pill use and apnea were less commonly reported, nearly 
1 in 10 reported either. Those with diabetes were more 
likely than those without diabetes to report multiple 
sleep problems (mean no. of problems, 3.1 vs 2.5; 
Figure).
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Figure. Number of reported sleep problems by diabetes status. The mean number of problems was 2.5 for the no-
diabetes group and 3.1 for the diabetes group. Differences between the 2 groups were significant at P < .001 in terms 
of both percentage distribution and mean number of problems (calculated by using χ  and t tests, respectively). [A 
tabular version of this figure is also available.]
Association of sleep problems with diabetes
Diabetes was associated with increased odds of inadequate sleep, frequent daytime sleepiness, restless legs symptoms, 
sleep apnea, and nocturia (Table 3). These associations were generally robust after adjustment for confounding factors. 
The magnitude of the associations of sleep apnea and, to a slightly lesser extent, inadequate sleep with diabetes was 
attenuated by adjustment for BMI but remained significant. The associations of diabetes with daytime sleepiness and 
inadequate sleep were rendered nonsignificant with the final adjustment for alcohol use.
Sensitivity analyses examining the association of sleep problems with diabetes defined only by glycohemoglobin showed 
similar results, except that the association between glycohemoglobin and sleep apnea was fully explained by BMI (data 
not shown). Results with diabetes defined by self-report, glychohemoglobin, and fasting plasma glucose were nearly 
identical to our primary analyses. When diabetes was examined by severity category (no diabetes, diabetes with 
glycohemoglobin <7.5%, diabetes with glycohemoglobin >7.5%), apnea, leg symptoms, daytime sleepiness, and nocturia 
(but not inadequate sleep) all showed greater odds with increasing severity in a significant, graded fashion. Diabetes 
duration was significantly associated with the same problems; risk increased 20% to 30% per 10 years since diagnosis.
Furthermore, the associations of diabetes with sleep problems were also similar among the subset of the population not 
reporting sleeping pill use (data not shown). Adjustment for other possible confounders generally did not substantially 
change the results: waist circumference was associated with sleep apnea (per 1-cm increase: OR, 1.03; 95% CI, 1.02-
1.05), but its addition to the model did not alter the association of diabetes with apnea (OR, 1.41; 95% CI, 1.02-1.95). 
Similarly, the association of diabetes with nocturia was not affected by either pulse pressure (OR, 1.48; 95% CI, 1.20-
1.84) or systolic blood pressure (OR, 1.48; 95% CI, 1.19-1.83). Higher income was generally associated with lower 
prevalence of sleep problems (with the exception of apnea, which showed the opposite association for the highest 
income category); however, its addition to the models did not affect the association of diabetes with sleep problems.
Stratified analyses showed that the association of sleep apnea, leg symptoms, and nocturia with diabetes was strongest 
among participants younger than 60 years old compared to those 60 or older (leg symptoms: OR, 1.94 vs 1.24; P = .006; 
apnea: OR, 3.52 vs 1.59; P < .001; and nocturia: OR, 3.09 vs 1.55; P < .001) (data not shown). The association of leg 
symptoms with diabetes was stronger among women than men (OR, 1.65 vs 1.28; P = .04). This effect modification by 
age and sex was not significant for any other sleep problem, and race/ethnicity did not modify the effect of these 
associations.
Discussion
We found that sleep problems are highly prevalent in the United States. More than 90% of NHANES respondents 
reported any examined sleep problem and 10% to 40% reported any given problem. Inadequate sleep, frequent daytime 
2
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sleepiness, apnea, leg symptoms, and nocturia were all more common among those with diabetes than those without 
diabetes. These associations persisted after adjustment for conditions that could contribute to poor sleep and were 
generally strongest among respondents who were younger and female. Although frequent sleeping pill use and severe 
sleep deprivation were both common, the prevalence of these problems did not differ by diabetes status.
The association of diabetes with sleep apnea, which was independent of obesity — a risk factor for both conditions — has 
been shown previously (10), as has our observed association between diabetes and restless legs symptoms (19), which 
may have neuropathic origins or be related to commonly used medications such as second-generation antidepressants 
and antihistamines. However, less is known about other sleep problems among people with diabetes. We found that 
nocturia and excessive sleepiness were also independently associated with diabetes. Nocturia was the most common 
sleep problem reported in this population, and the association with diabetes persisted even after adjustment for diuretic 
use. Nocturia is often not considered among the common sleep problems, but it may have deleterious effects on both 
sleep and quality of life (20), which was not assessed in this study. Inadequate sleep and excess sleepiness are similarly 
under-recognized (21) and detrimental to physical and mental health.
Although we have shown that diabetes is independently associated with increased risk of several sleep problems, the 
cross-sectional study design precludes causal inference, despite the magnitude and dose-response nature of the 
observed associations. Additionally, while we found that duration of diabetes was positively associated with increased 
risk of apnea, nocturia, leg symptoms, and daytime sleepiness — suggesting a possible temporal relationship between 
diabetes and subsequent sleep problems — we cannot definitively establish the directionality of the association. 
Previous research examining potential causal links between diabetes and sleep problems has been inconclusive. For 
example, a small study showed that forced sleep deprivation in healthy young men led to decreased leptin levels and 
increased appetite (22); another cross-sectional analysis of participants in the Sleep Heart Health Study showed that 
impaired glucose tolerance was more common among people with habitual sleep restriction (23), suggesting that sleep 
problems may lead to diabetes via physiologic mechanisms. However, the prevalence of sleep problems among patients 
with type 1 diabetes was found to be similar to that seen in type 2 diabetes (24). Given the difference in etiology, these 
results suggest that diabetes may also lead to sleep problems.
Other limitations of note include the self-report of sleep problems, which is subject to recall and detection bias. Data for 
neuropathy or chronic pain, pruritis, caffeine use, neck circumference, and 24-hour blood pressure were not available in 
the surveys analyzed. Restless legs symptoms may not be limited to leg cramps or jerks. Sleep studies were not 
performed. Although we were able to show that adjustment for income did not affect the association between diabetes 
and sleep problems, we did not have data on poverty-related stressors. Such stressors are thought to increase the 
“allostatic load” and both interfere with sleep and increase risk for chronic diseases such as diabetes (25).
However, our study also augments previous research on diabetes and sleep problems in several ways. It is a large, 
nationally representative study examining a comprehensive range of sleep problems, regardless of diagnosis. We were 
able to compare prevalence among people with diabetes to that of similar people without diabetes, to determine whether 
diabetes had an independent effect on sleep problems after adjustment for other factors strongly related to both 
diabetes and sleep, including age, sex, obesity, cardiovascular disease, depression, kidney disease, alcohol use, and 
income.
In conclusion, people with diabetes are more likely to have sleep problems than their counterparts of the same age, sex, 
and race/ethnicity without diabetes, regardless of several behaviors and comorbid conditions that could interfere with 
sleep. Because sleep problems and diabetes are both associated with poor quality of life (5,8), further research is 
warranted. Such efforts should examine the possibly dual directionality of the association of diabetes and sleep 
problems and explore possible causal inference and associated outcomes such as quality of life, ideally in a longitudinal 
cohort. Our results suggest that diabetes patients should be screened for these treatable sleep problems (sleep apnea, 
insomnia, restless legs, and nocturia). Recognition and treatment of sleep problems, particularly in the 
disproportionately affected younger and female diabetes populations, could considerably improve quality of life and, 
possibly, clinical outcomes among these patients.
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Table 1. Characteristics of the US Adult Population, Overall and by Diabetes 
Status, NHANES, 2005-2008
Characteristic
Total % (95% CI)  (N 
= 9,848) 
Diabetes Status, % (95% CI)
No Diabetes (n = 
8,424)





Mean age, y (95% CI) 46.7 (45.8-47.5) 45.5 (44.7-46.4) 58.9 (57.7-60.1) <.001
Sex
Male 48.0 (47.1-48.9) 47.9 (47.0-49.0) 48.5 (44.8-52.2)
.77
Female 52.0 (51.1-52.9) 52.1 (51.1-53.0) 51.5 (47.8-55.2)
Race/ethnicity
Non-Hispanic white 71.4 (66.5-75.8) 72.4 (67.7-76.6) 62.6 (54.2-70.3)
<.001Non-Hispanic black 10.7 (8.3-13.7) 9.9 (7.6-12.8) 17.7 (13.6-22.8)
Mexican American 8.2 (6.5-10.2) 8.1 (6.5-10.1) 8.8 (6.5-11.8)
Socioeconomic status
Education
<High school 18.9 (16.8-21.2) 17.7 (15.6-20.0) 29.1 (26.0-32.5)
<.001 
≥High school 81.1 (78.8-83.2) 82.3 (80.0-84.4) 70.9 (67.6-74.0)
Annual household income, $
<20,000 15.4 (13.9-17.1) 14.6 (13.1-16.2) 22.8 (19.5-26.4)
<.001 
20,000-44,999 27.8 (25.4-30.2) 27.1 (24.6-29.7) 33.8 (30.2-37.5)
45,000-74,999 24.2 (22.5-26.0) 24.6 (22.9-26.4) 21.0 (17.7-24.9)
≥75,000 32.6 (29.5-35.9) 33.8 (30.5-37.2) 22.3 (19.1-25.9)
Health insurance
Not insured 19.0 (16.9-21.2) 19.6 (17.6-21.9) 12.8 (10.4-15.7)
<.001 
Insured 81.0 (78.8-83.1) 80.3 (78.1-82.4) 87.2 (84.3-89.6)
Clinical status
Smoking
Every day 19.8 (17.8-21.9) 20.3 (18.1-22.6) 15.8 (13.3-18.7)
.01
Sometimes/not at all 80.2 (78.1-82.2) 79.8 (77.4-81.9) 84.2 (81.3-86.7)
Mean body mass index, kg/m  
(95% CI)
28.5 (28.3-28.8) 28.1 (27.7-28.3) 32.9 (32.3-33.5) <.001
Depression
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Not symptomatic by PHQ-9 94.9 (94.1-95.6) 95.1 (94.3-95.8) 92.9 (90.7-94.6)
Hypertension
Yes 41.8 (39.8-43.8) 38.4 (36.4-40.5) 71.8 (68.8-74.6)
<.001 
No 58.2 (56.2-60.2) 61.6 (59.5-63.6) 28.2 (25.4-31.2)
Cardiovascular disease
Yes 8.7 (7.8-9.6) 6.5 (5.8-7.4) 27.2 (24.0-30.7)
<.001 
No 91.3 (90.4-92.2) 93.5 (92.7-94.2) 72.8 (69.3-76.0)
Albuminuria status
UACR ≥30 mg/g 8.0 (7.2-8.8) 6.1 (5.5-6.9) 23.6 (20.6-26.8)
<.001 
UACR <30 mg/g 92.0 (91.2-92.8) 93.9 (93.2-94.5) 76.4 (73.2-79.4)
Reduced kidney function
eGFR <60 mL/min/1.73 m 8.3 (7.2-9.5) 7.0 (5.9-8.3) 19.5 (16.9-22.4)
<.001 
eGFR ≥60 mL/min/1.73 m 91.7 (90.5-92.8) 93.0 (91.7-94.1) 80.5 (77.6-83.1)
Mean alcoholic intake, no. of 
drinks/wk (95% CI)
3.8 (3.5-4.1) 4.0 (3.7-4.4) 2.1 (1.7-2.6) <.001
Diuretic use
Yes 6.0 (5.3-6.7) 5.4 (4.7-6.1) 11.3 (9.7-13.2)
<.001 
No 94.0 (93.3-94.7) 94.6 (93.9-95.3) 88.7 (86.8-90.3)
Abbreviations: NHANES, National Health and Nutrition Examination Survey; CI, confidence interval; PHQ-9, patient health 
questionnaire, 9-item; UACR, urinary albumin:creatinine ratio; eGFR, estimated glomerular filtration rate. 
 Values are percentages except where indicated by the word “mean.” 
 Calculated by using χ  tests for categorical variables and analysis of variance for continuous variables. 
 Other race/ethnicity category (including other Hispanic, Asian, Pacific Islander, and Native American) not shown because of 
within-category heterogeneity, but respondents in “other” category are included in all analyses. 
 Self-reported or measured blood pressure ≥140/90 mm Hg. 
 Self-reported.
 






Severe sleep deprivation 28.7
Nocturia 24.5
Frequent daytime sleepiness 18.6
Frequent sleeping pill use 9.1
Apnea 8.9
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Table 3. Odds of Sleep Problems for People With Diabetes, NHANES, 2005-2008






















Abbreviations: NHANES, National Health and Nutrition Examination Survey; OR, odds ratio; CI, confidence interval. 
 See Box in Methods for definitions. 
 Data were adjusted for age, sex, race/ethnicity, body mass index (continuous), cardiovascular disease, depression, 
albuminuria, kidney function, diuretic use, and alcohol use.
Post-Test Information
To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the 
following, related, multiple-choice questions. To complete the questions (with a minimum 70% passing score) and earn 
continuing medical education (CME) credit, please go to http://www.medscape.org/journal/pcd . Credit cannot be 
obtained for tests completed on paper, although you may use the worksheet below to keep a record of your answers. You 
must be a registered user on Medscape.org. If you are not registered on Medscape.org, please click on the “Register” link 
on the right hand side of the website to register. Only one answer is correct for each question. Once you successfully 
answer all post-test questions you will be able to view and/or print your certificate. For questions regarding the content 
of this activity, contact the accredited provider, CME@medscape.net. For technical assistance, contact 
CME@webmd.net. American Medical Association’s Physician’s Recognition Award (AMA PRA) credits are accepted in 
the US as evidence of participation in CME activities. For further information on this award, please refer to 
http://www.ama-assn.org/ama/pub/category/2922.html . The AMA has determined that physicians not licensed in 
the US who participate in this CME activity are eligible for AMA PRA Category 1 Credits™. Through agreements that 
the AMA has made with agencies in some countries, AMA PRA credit may be acceptable as evidence of participation in 
CME activities. If you are not licensed in the US, please complete the questions online, print the AMA PRA CME credit 
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For Questions About This Article Contact pcdeditor@cdc.gov
Page last reviewed: April 04, 2012
Page last updated: April 04, 2012
Content source: National Center for Chronic Disease Prevention and Health Promotion
Post-Test Questions
Article Title:  Prevalence of Self-Reported Sleep Problems Among People With 
Diabetes in the United States, 2005-2008
CME Questions
On the basis of the study of 2005-2008 NHANES data by Dr. Plantinga and colleagues, which of the following 
statements about the overall prevalence of sleep problems among persons with diabetes is most likely correct? 
1.
About half of persons in the survey reported having any sleep problem.A.
Among persons with diabetes, the mean number of sleep problems was about 2.B.
The study proves that diabetes causes sleep problems.C.
People with diabetes are more likely to have sleep problems than are persons of the same age, sex, and 
race/ethnicity without diabetes.
D.
On the basis of the study of 2005-2008 NHANES data by Dr. Plantinga and colleagues, which of the following 
statements about factors modifying the prevalence of sleep problems among persons with diabetes is most likely 
correct? 
2.
Adjustment for conditions that could contribute to poor sleep abolished the observed associations between 
sleep problems and diabetes.
A.
The observed associations between sleep problems and diabetes were strongest among older respondents.B.
The observed associations between sleep problems and diabetes were stronger in men than in women.C.
Duration of diabetes was positively associated with increased risk for specific sleep problems.D.
Your patient is a 56-year-old man with type 2 diabetes. On the basis of the study of 2005-2008 NHANES data by 
Dr. Plantinga and colleagues, which of the following statements about the prevalence of specific sleep problems 
would most likely be correct? 
3.
Adjusted risk for restless legs symptoms is increased by about 40% compared with someone without diabetes.A.
He is at increased risk for frequent sleeping pill use compared with someone without diabetes.B.
He is at increased risk for severe sleep deprivation compared with someone without diabetes.C.
After adjustment for diuretic use, risk for nocturia is not increased compared with persons without diabetes.D.
Evaluation
1. The activity supported the learning objectives.
Strongly Disagree    Strongly Agree 
1 2 3 4 5
2. The material was organized clearly for learning to occur. 
Strongly Disagree    Strongly Agree 
1 2 3 4 5
3. The content learned from this activity will impact my practice. 
Strongly Disagree    Strongly Agree 
1 2 3 4 5
4. The activity was presented objectively and free of commercial bias. 
Strongly Disagree    Strongly Agree 
1 2 3 4 5
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Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA 
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, New Hours of Operation 8am-8pm ET/Monday-Friday 
Closed Holidays - cdcinfo@cdc.gov
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